14/03/2019 22:45:45

Syneos Health Schedules Fourth Quarter and Year End 2018 Earnings Call for Monday, March 18, 2019

MORRISVILLE, N.C., March 14, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization combining a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), will release its fourth quarter and year end 2018 financial results and file its Form 10-K for the fiscal year ended December 31, 2018, after the market closes on Monday, March 18, 2019. The Company will host its earnings call at 5:30 p.m. ET that afternoon.

Participants may access the conference call live via webcast on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com. To participate via telephone, please dial +1 877 930 8058 within the United States or +1 253 336 7551 outside the United States, approximately 15 minutes prior to the scheduled start time. The conference ID for the call is 3768756.

A webcast replay will be available on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com after 8:30 p.m. on March 18. In addition, an audio replay will be available for one week following the call and will be accessible by dialing +1 855 859 2056 within the United States or +1 404 537 3406 outside the United States. The replay ID is 3768756.

About Syneos Health

Syneos Health™ (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 23,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life® visit syneoshealth.com.

   

Investor Relations Contact:

 

Press/Media Contact:

Ronnie Speight Danielle DeForge
Senior Vice President, Investor Relations Executive Director, External Communications
+1 919 745 2745 +1 781 425 2624

investor.relations@syneoshealth.com

 

danielle.deforge@syneoshealth.com

   

Syneos Health_rgb_tm.png

Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
13 Mar
 
Skam dig selv. Jeg synes faktisk dit udsagn er urimeligt. Vedkommende har i god tro købt lidt aktier..
15
12 Mar
DANSKE
Finans bringer i dag en liste over de højest gagerede bankfolk i EU   5000 tjener over 1 mio.€ (hera..
15
18 Mar
GOMX
SAS's emmision overtegnet så de regner med 15MUSD i provenu samlet - godt nyt for GOMSpace hvis de k..
14
14 Mar
BA
Elliot.Blot for info så har jeg cirka 14.000 timer på 737 serien og der er altid problemer når en ty..
14
14 Mar
DANSKE
Danske Bank er sværd at værdiansætte set i forhold til den situation som Danske Bank befinder sig i...
12
13 Mar
ZEAL
Der er nogle enkelt punkter som jeg har noteret mig under læsningen af Årsrapporten 2018 samt de sen..
12
18 Mar
BAVA
For mig virker det ret underligt at udmelding fra FDA om ydereligere 3mdr mere behandlingstid bliver..
11
15 Mar
PNDORA
Det forhold, at Pandora på trods af negativ analyse fra Carnegie og udbetaling af udbytte har holdt ..
11
13 Mar
VELO
https://www.marketwatch.com/press-release/organ-transplantation-market-to-ascent-exponentially-at-98..
11
12 Mar
NOVO-B
Novo er nu tæt på et pas på område for de kortsigetede. Så jeg vil være OBS på, om købssignalerne æn..
11

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
HPV Vaccine Mandate Ill-Advised, States Association of American Physicians and Surgeons (AAPS)
2
AzurRx BioPharma Announces Presentation on Its Positive Phase II Data in MS1819-SD in Chronic Pancreatitis at the 2019 Digestive Disease Week Conference
3
Jumio Partners with ComplyAdvantage to Reduce AML Risk Exposure
4
Global Gaming’s X2 Games Announces the Launch of Pre-Orders for its Cutting-Edge Amazon Alexa Powered Board Game St. Noire
5
BOXX Showcases Data Science Workstation and Other Solutions at GTC

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
19 March 2019 10:43:51
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: ReleaseBuild_20190215.1 - EUROWEB2 - 2019-03-19 11:43:51 - 2019-03-19 10:43:51 - 1000 - Website: OKAY